A share price of ICU Medical, Inc [ICUI] is currently trading at $149.14, down -1.82%. An important factor to consider is whether the stock is rising or falling in short-term value. The ICUI shares have gain 12.50% over the last week, with a monthly amount glided 24.17%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ICU Medical, Inc [NASDAQ: ICUI] stock has seen the most recent analyst activity on August 15, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $145. Previously, Raymond James upgraded its rating to Strong Buy on March 12, 2025, and dropped its price target to $197. On December 11, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $200 on the stock. Jefferies started tracking the stock assigning a Hold rating and suggested a price target of $183 on October 14, 2024. Needham initiated its recommendation with a Hold. Raymond James upgraded its rating to Outperform for this stock on June 17, 2024, but kept the price target unchanged to $135. In a note dated November 08, 2022, Raymond James downgraded an Mkt Perform rating on this stock.
ICU Medical, Inc experienced fluctuations in its stock price throughout the past year between $107.00 and $175.51. Currently, Wall Street analysts expect the stock to reach $163 within the next 12 months. ICU Medical, Inc [NASDAQ: ICUI] shares were valued at $149.14 at the most recent close of the market. An investor can expect a potential return of 9.29% based on the average ICUI price forecast.
Analyzing the ICUI fundamentals
Trailing Twelve Months sales for ICU Medical, Inc [NASDAQ:ICUI] were 2.32B which represents -8.61% decline. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 148.04 points at the first support level, and at 146.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 151.19, and for the 2nd resistance point, it is at 153.25.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ICU Medical, Inc [NASDAQ:ICUI] is 2.43. On the other hand, the Quick Ratio is 1.16, and the Cash Ratio is 0.61. Considering the valuation of this stock, the price to sales ratio is 1.59, the price to book ratio is 1.73.
Transactions by insiders
Recent insider trading involved DANIEL WOOLSON, Officer, that happened on Nov 25 ’25 when 2897.0 shares were purchased. VP, GM-Infusion Capital, Woolson Daniel completed a deal on Nov 25 ’25 to sell 2897.0 shares. Meanwhile, Director FINNEY ELISHA W sold 1285.0 shares on Nov 11 ’25.
